Platelet-derived endothelial cell growth factor/thymidine phosphorylase concentrations differ in small cell and non-small cell lung cancer

Chest

Volumn 116, Issue 1, 1999, Pages 206-211

  Yamashita, Jun Ichi ^a   Ogawa, Michio ^a   Abe, Michio ^a   Nishida, Miwa ^b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Non small cell lung cancer; Platelet derived endothelial cell growth factor; Small cell lung cancer; Thymidine phosphorylase

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TISSUE LEVEL;

EID: 0032772187     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.1.206     Document Type: Article

References (38)

1. 1 Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82:4-6
2. 2 Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032:89-118
3. 3 Weidner N. The relationship of tumor angiogenesis and metastasis with emphasis on invasive breast carcinoma. In: Advances in pathology (vol 5). Chicago, IL: Mosby Year-Book, 1992; 101-122
4. 4 Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 4:1875-1887
5. 5 Dickinson A, Fox SB, Persad R, et al. Quantitation of angiogenesis is an independent predictor of prognosis in invasive bladder cancer. Br J Urol 1994; 74:762-766
6. 6 Srivastava A, Laidler P, Davies R, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4 mm thick) skin melanoma. Am J Pathol 1988; 133:419-423
7. 7 Silberman MA, Partin AW, Veltri RW, et al. Tumor angiogenesis correlates with progression after radical prostatectomy but not pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 1997; 79:772-779
8. 8 Liotta LA, Stracke ML. Tumor invasion and metastasis: biochemical mechanisms. Cancer Treat Res 1988; 40:223-238
9. 9 Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974; 34:997-1004
10. 10 Miyazono K, Okabe T, Urabe A, et al. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987; 262:4098-4103
11. 11 Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989; 338:557-562
12. 12 Miyadera K, Sumizawa T, Haraguchi M, et al. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 1995; 55:1687-1690
13. 13 Moghaddam A, Zhang HT, Fan TP, et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Nad Acad Sci USA 1995; 92:998-1002
14. 14 Haraguchi M, Miyadera K, Uemura K, et al. Angiogenic activity of enzymes [letter]. Nature 1994; 368:198
15. 15 Usuki K, Heldin NE, Miyazono K, et al. Production of platelet-derived endothelial cell growth factor by normal and transformed human cell growth factor by normal and transformed human cells in culture. Proc Nad Acad Sci USA 1989; 86:7427-7431
16. 16 Toi M, Hoshina S, Taniguchi T, et al. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995; 64:79-82
17. 17 Fox SB, Westwood M, Moghaddam A, et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 1996; 73:275-280
18. 18 Reynolds K, Frazaneh F, Collins WP, et al. Correlation of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994; 86:1234-1238
19. 19 O'Brien TS, Fox SB, Dickinson AJ, et al. Expression of angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 1996; 56:4799-4804
20. 20 Kubota Y, Miura T, Moriyama M, et al. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer. Clin Cancer Res 1997; 3:973-976
21. 21 Mizutani Y, Okada Y, Yoshida O. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer 1997; 79:1190-1194
22. 22 Takahashi Y, Bucana CD, Akagi Y, et al. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin Cancer Res 1998; 4:429-434
23. 23 Takahashi Y, Bucana CD, Liu W, et al. Platelet-derived endothelial cell growth factor in human colon cancer angio-genesis: role of infiltrating cells. J Natl Cancer Inst 1996; 88:1146-1151
24. 24 Takebayashi Y, Akiyama S, Akiba S, et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996; 88:1110-1117
25. 25 Koukourakis MI, Giatromanolaki A, O'Byrne KJ, et al. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Br J Cancer 1997; 75:477-481
26. 26 Nishida M, Hino A, Mori K, et al. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996; 19:1407-1411
27. 27 The World Health Organization histological typing of lung tumours. Am J Clin Pathol 1982; 77:123-136
28. 28 Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
29. 29 Yamashita J, Ogawa M, Abe M, et al. Tumor neutrophil elastase is closely associated with the direct extension of non-small cell lung cancer into the aorta. Chest 1997; 111: 885-890
30. 30 Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275
31. 31 Tandon AK, Clark GM, Chamness GC, et al. Cathepsin D and prognosis in breast cancer. N Engl J Med 1990; 322:297-302
32. 32 Satos GA, Grogan L, Allegra CJ. Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treat Rev 1994; 20:11-49
33. 33 Juczewska M, Chyczewski L, Telego M, et al. Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage. Rocz Akad Med Bialymst 1997; 42(suppl):254-270
34. 34 Giatromanolaki A, Koukourakis MI, Comley M, et al. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol 1997; 181:196-199
35. 35 Heldin NE, Usuki K, Bergh J, et al. Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines. Br J Cancer 1993; 68:708-711
36. 36 Mountain CF. Clinical biology of small cell lung cancer: relationship to surgical therapy. Semin Oncol 1978; 5:272-279
37. 37 Fox SB, Moghaddam A, Westwood M, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 1995; 176:183-190
38. 38 Koukourakis MI, Giatromanolaki A, Kakolyris S, et al. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival. Br J Cancer 1998; 77:1696-1703